Literature DB >> 1540415

HIV-1 protease cleaves actin during acute infection of human T-lymphocytes.

L D Adams1, A G Tomasselli, P Robbins, B Moss, R L Heinrikson.   

Abstract

Actin, one of the most abundant proteins of the cell, is hydrolyzed by the human immunodeficiency virus type 1 (HIV-1) protease during acute infection of cultured human T lymphocytes. The actin fragments produced during the course of infection are identical to those obtained by recombinant HIV-1 protease digests of (1) a lysate from uninfected T lymphocytes and (2) globular actin itself. Hydrolysis by the HIV-1 protease of physiologically important host cellular proteins during infection may have important consequences relative to viral pathogenesis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1540415     DOI: 10.1089/aid.1992.8.291

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  14 in total

1.  Toxins that are activated by HIV type-1 protease through removal of a signal for degradation by the N-end-rule pathway.

Authors:  P O Falnes; R Welker; H G Kräusslich; S Olsnes
Journal:  Biochem J       Date:  1999-10-01       Impact factor: 3.857

2.  Reversible oxidative modification as a mechanism for regulating retroviral protease dimerization and activation.

Authors:  David A Davis; Cara A Brown; Fonda M Newcomb; Emily S Boja; Henry M Fales; Joshua Kaufman; Stephen J Stahl; Paul Wingfield; Robert Yarchoan
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

Review 3.  Translation initiation of the HIV-1 mRNA.

Authors:  Théophile Ohlmann; Chloé Mengardi; Marcelo López-Lastra
Journal:  Translation (Austin)       Date:  2014-10-31

4.  Cleavage of human and mouse cytoskeletal and sarcomeric proteins by human immunodeficiency virus type 1 protease. Actin, desmin, myosin, and tropomyosin.

Authors:  R L Shoeman; C Sachse; B Höner; E Mothes; M Kaufmann; P Traub
Journal:  Am J Pathol       Date:  1993-01       Impact factor: 4.307

5.  Potent inhibition of human immunodeficiency virus type 1 (HIV-1) replication by inducible expression of HIV-1 PR multimers.

Authors:  S J Arrigo; K Huffman
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

6.  Human immunodeficiency virus type 1 protease cleaves procaspase 8 in vivo.

Authors:  Zilin Nie; Gary D Bren; Stacey R Vlahakis; Alicia Algeciras Schimnich; Jason M Brenchley; Sergey A Trushin; Sarah Warren; David J Schnepple; Colin M Kovacs; Mona R Loutfy; Daniel C Douek; Andrew D Badley
Journal:  J Virol       Date:  2007-04-18       Impact factor: 5.103

Review 7.  Toxin-based therapeutic approaches.

Authors:  Assaf Shapira; Itai Benhar
Journal:  Toxins (Basel)       Date:  2010-10-28       Impact factor: 4.546

Review 8.  Casp8p41: The Protean Mediator of Death in CD4 T-cells that Replicate HIV.

Authors:  Rahul Sampath; Nathan W Cummins; Andrew D Badley
Journal:  J Cell Death       Date:  2016-09-27

9.  Analysis of HIV Protease Killing Through Caspase 8 Reveals a Novel Interaction Between Caspase 8 and Mitochondria.

Authors:  Alicia Algeciras-Schimnich; Anne-Sophie Belzacq-Casagrande; Gary D Bren; Zilin Nie; Julie A Taylor; Stacey A Rizza; Catherine Brenner; Andrew D Badley
Journal:  Open Virol J       Date:  2007-12-27

10.  HIV-1 protease-induced apoptosis.

Authors:  Michaela Rumlová; Ivana Křížová; Alena Keprová; Romana Hadravová; Michal Doležal; Karolína Strohalmová; Iva Pichová; Miroslav Hájek; Tomáš Ruml
Journal:  Retrovirology       Date:  2014-05-20       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.